Food & Drug Administration (FDA) approved the GLP-1 drug Wegovy to help reduce the risk of serious heart problems among people who are overweight or have obesity who do not necessarily have type 2 diabetes
Brushing your teeth immediately before or after dosing is another mistake
Whether you seek a flexible routine or a proven weight management solution, our experts analyze your situation, incorporating insurance coverage and personal preferences into your plan
GLP-1 medications work by activating appetite-control receptors in the brain
The steady-state 24-hour urinary glucose excretion in patients with type 2 diabetes mellitus and mild, moderate, and severe renal impairment was 42%, 80%, and 90% lower, respectively, than in patients with type 2 diabetes mellitus with normal renal function
Vendor relationship maintenance: Long-term research benefits from stable vendor relationships